NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.
February 14, 2024 - Surescripts last week issued the following Advisory to pharmacies, pharmacy computer vendors and electronic health records companies connected to their e-prescribing network.
Description: As of August 28, 2023, the electronic transfer...
The Regulatory Drafting and Policy Support Section of the US Drug Enforcement Administration is looking for additional comments on the disposal APRN published on 10-31-2023 at Read More
On Feb. 1, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a final rule that updates regulations for Opioid Treatment Programs (OTP) and the standards for treatment of opioid use disorder (OUD). The rule makes some COVID-19-related flexibilities permanent, including...
On Jan. 16, 2024, DEA launched a redesigned website to better educate the community of more than 1.2 million registrants on DEA?s role in to keeping communities safe through prevention of the diversion of controlled substances.
Check out the redesigned website: Read More
December 13, 2023
JEFFERSON CITY, Mo. ? The State of Missouri?s statewide prescription drug monitoring program (PDMP) was activated on Wednesday, December 13, 2023. The purpose of PDMP is to reduce abuse and misuse of controlled substances such as opioids by making...
Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us. For the District of Columbia, Guam, and Puerto Rico, please use the button on the left for the inclusive drop down list.